Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor

Full text
Author(s):
Show less -
de Melo, Suely Maymone [1] ; Bittencourt, Simone [2] ; Ferrazoli, Eneas Galdini [2] ; da Silva, Clivandir Severino [2] ; da Cunha, Flavia Franco [1] ; da Silva, Flavia Helena [1] ; Stilhano, Roberta Sessa [1] ; Andrade Denapoli, Priscila Martins [1] ; Zanetti, Bianca Ferrarini [1] ; Matsumoto Martin, Priscila Keiko [1] ; Silva, Leonardo Martins [1] ; dos Santos, Adara Aurea [1] ; Baptista, Leandra Santos [3] ; Longo, Beatriz Monteiro [2] ; Han, Sang Won [4, 1]
Total Authors: 15
Affiliation:
[1] Univ Fed Sao Paulo, Res Ctr Gene Therapy CINTERGEN, Sao Paulo - Brazil
[2] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo - Brazil
[3] Univ Fed Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol, Numpex Bio, Sao Paulo - Brazil
[4] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: PLoS One; v. 10, n. 6 JUN 12 2015.
Web of Science Citations: 26
Abstract

Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted to GBM and kill tumor cells via a bystander effect. To use this strategy, abundantly present adipose-tissue-derived mesenchymal stem cells (AT-MSCs) were evaluated for the treatment of GBM in mice. AT-MSCs were prepared using a mechanical protocol to avoid contamination with animal protein and transduced with HSV-Tk via a lentiviral vector. The U-87 glioblastoma cells cultured with AT-MSC-HSV-Tk died in the presence of 25 or 50 mu M ganciclovir (GCV). U-87 glioblastoma cells injected into the brains of nude mice generated tumors larger than 3.5 mm(2) after 4 weeks, but the injection of AT-MSC-HSV-Tk cells one week after the U-87 injection, combined with GCV treatment, drastically reduced tumors to smaller than 0.5 mm(2). Immunohistochemical analysis of the tumors showed the presence of AT-MSC-HSV-Tk cells only within the tumor and its vicinity, but not in other areas of the brain, showing chemoattraction between them. The abundance of AT-MSCs and the easier to obtain them mechanically are strong advantages when compared to using MSCs from other tissues. (AU)

FAPESP's process: 12/21861-1 - Development of DNA vaccine against tumors expressing CEA using scFv (Single Chain Fragment Variable) derived of the idiotypic antibody 6.C4
Grantee:Sang Won Han
Support Opportunities: Regular Research Grants